Mrs Persis Daniels, MA,CCC-SLP/A | |
12425 Mill House Drive, Geismar, LA 70734 | |
(225) 673-6837 | |
Not Available |
Full Name | Mrs Persis Daniels |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 12425 Mill House Drive, Geismar, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225267073 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Mrs Persis Daniels, MA,CCC-SLP/A 12425 Mill House Drive, Geismar, LA 70734 Ph: (225) 673-6837 | Mrs Persis Daniels, MA,CCC-SLP/A 12425 Mill House Drive, Geismar, LA 70734 Ph: (225) 673-6837 |
News Archive
New research suggests that ibuprofen may offer protection against developing Parkinson's disease, according to one of the largest studies to date investigating the possible benefits of the over-the-counter drug on the disease. The study is published in the March 2, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.
RMIT University is collaborating with partners including Australian biomedical start-up Soterius on the biosensor, which can detect the presence of tiny amounts of the SARS-CoV-2 virus and its variants.
The incidence and severity of both traditional and emerging cardiovascular disease (CVD) risk factors as well as the response to treatment may differ between genders. In this narrative review, several emerging CVD risk factors (i.e. inflammatory and haemostatic markers, endothelial dysfunction, homocysteine, lipid disorders, microalbuminuria/proteinuria, coronary artery calcium score, arterial stiffness, periodontitis, inflammatory bowel syndrome, obstructive sleep apnea, impaired glucose metabolism, metabolic syndrome and non-alcoholic fatty liver disease) are discussed in the context of gender differences.
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.
Work by University of Manchester scientists has explored what allows some cases of Ductal Carcinoma in Situ (DCIS), a non-invasive form of breast cancer, to resist treatment and come back, as well as identifying a potential new target to improve the effectiveness of radiotherapy.
› Verified 5 days ago
Mrs. Ayanna Colomb Carmouche, MS -L -SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 37426 Cypress Place Ave, Geismar, LA 70734 Phone: 337-280-1666 | |
Tammi E Marshall, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12316 Old Mill Dr, Geismar, LA 70734 Phone: 225-505-6680 | |
Mrs. Ashleigh Pipes Frederic, M.C.D.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 37168 Grist Mill Ave, Geismar, LA 70734 Phone: 225-313-4337 | |
Mrs. Candice Moree Gray, M.A., CCC-S.L.P. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10510 Shadowlake Dr, Geismar, LA 70734 Phone: 225-647-7221 |